GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (MEX:TAK N) » Definitions » Common Stock

Takeda Pharmaceutical Co (MEX:TAK N) Common Stock : MXN229,779 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Common Stock?

Takeda Pharmaceutical Co's quarterly common stock increased from Jun. 2024 (MXN194,574 Mil) to Sep. 2024 (MXN233,420 Mil) but then declined from Sep. 2024 (MXN233,420 Mil) to Dec. 2024 (MXN229,779 Mil).

Takeda Pharmaceutical Co's annual common stock declined from Mar. 2022 (MXN281,471 Mil) to Mar. 2023 (MXN226,060 Mil) and declined from Mar. 2023 (MXN226,060 Mil) to Mar. 2024 (MXN185,726 Mil).


Takeda Pharmaceutical Co Common Stock Historical Data

The historical data trend for Takeda Pharmaceutical Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Common Stock Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 363,287.16 313,696.73 281,470.77 226,059.75 185,726.04

Takeda Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 197,650.79 185,726.04 194,573.75 233,420.29 229,779.16

Takeda Pharmaceutical Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Takeda Pharmaceutical Co Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines